Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disseminated Malignant Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07492121
What this trial is testing

Screening for Brain Metastases

Who this might be right for
Lung Cancer Stage IVMelanoma Stage IVBreast Cancer Metastatic
University of Zurich 180
Not applicableStudy completedNCT05087095
What this trial is testing

Managing Distress in Malignant Brain Cancer

Who this might be right for
Cancer Metastatic to BrainBrain Metastases, Adult
Virginia Commonwealth University 13
Large-scale testing (Phase 3)Study completedNCT01372774
What this trial is testing

Stereotactic Radiosurgery or Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases That Have Been Removed By Surgery

Who this might be right for
Cognitive/Functional EffectsMetastatic CancerNeurotoxicity+2 more
Alliance for Clinical Trials in Oncology 194
Testing effectiveness (Phase 2)Study completedNCT02049060
What this trial is testing

Study of the Combination of Tivantinib Plus Pemetrexed and Carboplatin

Who this might be right for
Malignant Pleural MesotheliomaNonsquamous Nonsmall Cell Neoplasm of Lung
Armando Santoro, MD 31
Early research (Phase 1)Study completedNCT05990920
What this trial is testing

Study of Allogeneic Blood-derived Natural Killer Cells to Evaluate Safety and Tolerability in Cancer Refractory to Conventional Therapy

Who this might be right for
Pathologically Confirmed Cancer Refractory to Conventional TherapyRefractory CancerMetastatic Cancer+5 more
NKGen Biotech, Inc. 6
Large-scale testing (Phase 3)Study completedNCT00003724
What this trial is testing

Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases

Who this might be right for
Metastatic Cancer
Alliance for Clinical Trials in Oncology 530
Early research (Phase 1)Study completedNCT00327223
What this trial is testing

Safety Study of Imexon Treatment of Patients With Metastatic or Disseminated Malignancy

Who this might be right for
Neoplasm Metastasis
AmpliMed Corporation 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07621159
What this trial is testing

A Phase Ib/II Study of HDM2017 in Combination With Standard of Care in Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 120
Not applicableLooking for participantsNCT06864338
What this trial is testing

Pilot Study for Colorectal Cancer and Advanced Adenoma Detection With the Mainz Biomed Colorectal Cancer Test

Who this might be right for
Colorectal Cancer ScreeningColorectal Cancer MetastaticColon Adenocarcinoma
Mainz Biomed 2,700
Not applicableStudy completedNCT04400656
What this trial is testing

PROState Pathway Embedded Comparative Trial

Who this might be right for
Prostate CancerNon-metastatic Prostate CancerMetastatic Prostate Cancer+3 more
Imperial College London 139
Not applicableNot Yet RecruitingNCT06682247
What this trial is testing

A Real-world Study of Chidamide in Combination with PD-1/PD-L1 Antibodies and Anti-angiogenic Agents in Advanced MSS Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
Feng Wang 200
Not applicableLooking for participantsNCT06547710
What this trial is testing

Primary Tumor Resection for M1a Stage Lung Cancer

Who this might be right for
Lung Cancer MetastaticSurgical Resection
Fudan University 66
Not applicableLooking for participantsNCT04907643
What this trial is testing

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

Who this might be right for
Cancer PainVisceral PainGastrointestinal Neoplasms+76 more
Cedars-Sinai Medical Center 360
Testing effectiveness (Phase 2)WithdrawnNCT04483414
What this trial is testing

68Ga PSMA-11 PET/CT in Recurrent Prostate Cancer

Who this might be right for
Prostate CancerProstate Cancer MetastaticProstate Cancer Metastatic to Bone
Dana Mathews
Not applicableUnknownNCT05560035
What this trial is testing

The Effect of Intravenous Lidocaine on THBS2 and Angiogenic Factors Expression in Women Undergoing Cervical Cancer Surgery

Who this might be right for
Cervical CancerMetastatic Cancer
General Hospital of Ningxia Medical University 60
Early research (Phase 1)Active Not RecruitingNCT05378425
What this trial is testing

NTX-1088, a Monoclonal Antibody Targeting the Poliovirus Receptor (PVR, CD155), as Monotherapy and Combined With Pembrolizumab

Who this might be right for
CancerTumor, SolidAdvanced Solid Tumor+2 more
Nectin Therapeutics Ltd 90
Early research (Phase 1)Study completedNCT03024216
What this trial is testing

Clinical Study of Atezolizumab (Anti-PD-L1) and Sipuleucel-T in Patients With Asymptomatic or Minimally Symptomatic Metastatic Castrate Resistant Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic
University of Hawaii 37
Early research (Phase 1)Study completedNCT04678921
What this trial is testing

Study of TJ210001 Administered in Subjects With Relapsed or Refractory Advanced Solid Tumors

Who this might be right for
Solid TumorMetastatic CancerAdvanced Cancer
I-Mab Biopharma US Limited 16
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06959589
What this trial is testing

The Efficacy and Safety of IBI351, Cetuximab β Combined With FOLFIRI as First-line /IBI351, Cetuximab β as Second-line in the Treatment of KRAS G12C-mutated Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer MetastaticKRAS G12C Mutation
Second Affiliated Hospital, Zhejiang University, School of Medicine 50
Testing effectiveness (Phase 2)Study completedNCT01298713
What this trial is testing

Tamoxifen-RAD001 Versus Tamoxifen Alone in Patients With Anti-aromatase Resistant Breast Metastatic Cancer

Who this might be right for
Breast NeoplasmsmTor Protein
ARCAGY/ GINECO GROUP 111
Next Page